Billionaire Jim Mellon invests in anti-ageing research firm - Pharmaphorum

img 10.04.2017

Billionaire biotechnology investor Jim Mellon has unveiled an investment in an ambitious new venture which seeks to tackle ageing and age-related diseases. Insilico Medicine is a big data analytics company which says its mission is to ‘extend healthy longevity’. This is a ‘moonshot’ target in health which has seen investment from a number of ambitious research groups in the last few years. ...

See source

Contact Form c